Daniela Gottardi

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial

Antonio Palumbo, Davide Rossi, Maide Cavalli et al. · Journal of Clinical Oncology · 2010 · 426 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

Luisa Granziero, Paolo Ghia, Paola Circosta et al. · Blood · 2001 · 335 citations · Full text

Life Sciences, Molecular Biology, Oncology +6

MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation

Alessandra Stacchini, M. Aragno, Antonella Vallario et al. · Leukemia Research · 1999 · 278 citations

Life Sciences, Cell Biology, Hematology +9

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression

Paolo Ghia, Giuseppe Guida, Stefania Stella et al. · Blood · 2003 · 256 citations

Medicine, Hematology, Oncology +12

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

Antonio Palumbo, Sara Bringhen, Alessandra Larocca et al. · Journal of Clinical Oncology · 2014 · 210 citations · Full text

Medicine, Hematology, Pharmacotherapy +16